The oncolytic virus pelareorep primes the tumor microenvironment for checkpoint blockade therapy in early breast cancer patients – Results from AWARE-1 study

Gavilá, Joaquín et al, Previously presented at the European Society for Medical Oncology Breast Cancer 2022 Meeting; May 3-5, 2022